Editas Medicine Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.24

+0.04 (+1.25%)

As of Jun 30, 10:26 PM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 13 68%

Hold 4 21%

Sell 2 11%

Price Target

Analyst Price Target +295.4% upside

Low Target $8.62

Average Target $12.81

High Target $14.59

Current Price $3.24

Current
$3.24

Target
$12.81

$8.62 $12.81 avg $14.59

Scenario Analysis

Bear Case

$8.62

166.0%

Low target

Base Case

$12.81

+295.4%

Avg target

Bull Case

$14.59

+350.3%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$4.54

-28.6% from high

52-Week Low

$1.66

+95.2% from low

Target vs 52W High

$12.81

+182.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%